MCID: ALX002
MIFTS: 37

Alexithymia malady

Category: Mental diseases

Aliases & Classifications for Alexithymia

About this section

Aliases & Descriptions for Alexithymia:

Name: Alexithymia 11 13

Classifications:



External Ids:

Disease Ontology11 DOID:0060131

Summaries for Alexithymia

About this section
Wikipedia:71 Alexithymia /ˌeɪlɛksəˈθaɪmiə/ is a personality construct characterized by the... more...

MalaCards based summary: Alexithymia is related to personality disorder and alopecia. An important gene associated with Alexithymia is ANKK1 (Ankyrin Repeat And Kinase Domain Containing 1), and among its related pathways are Neurotransmitter Clearance In The Synaptic Cleft and Paroxetine Pathway, Pharmacokinetics. Affiliated tissues include brain, breast and testes, and related mouse phenotype Weakly decreased NFAT1-GFP nuclear translocation.

Disease Ontology:11 An agnosia that is a deficiency in understanding, processing, or describing emotions.

Related Diseases for Alexithymia

About this section

Diseases related to Alexithymia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 152)
idRelated DiseaseScoreTop Affiliating Genes
1personality disorder29.7COMT, DRD2, HTR1A, SLC6A4
2alopecia29.5ANKK1, DRD2, SLC6A4
3schizophrenia28.6ANKK1, COMT, CRP, DRD2, HTR1A, OXTR
4social emotional agnosia10.8
5nephronophthisis 1310.3COMT, SLC6A4
6clostridium difficile colitis10.2IL4, SLC6A4
7intrahepatic gall duct cancer10.2COMT, SLC6A4
8intracranial cavernous angioma10.2DRD2, SLC6A4
9splenic abscess10.2DRD2, SLC6A4
10ornithosis10.2DRD2, SLC6A4
11rhinoscleroma10.2COMT, DRD2
12euthyroid sick syndrome10.2DRD2, SLC6A4
13pyromania10.2DRD2, SLC6A4
14c8 deficiency, type ii10.2COMT, DRD2
15testicular leydig cell tumor10.2COMT, IL4
16intracranial aneurysm10.1ANKK1, DRD2
1718p deletion syndrome10.1ANKK1, DRD2
18urea cycle disorder10.1COMT, DRD2
19interstitial emphysema10.1DRD2, SLC6A4
20nephrogenic adenoma of the urethra10.1DRD2, SLC6A4
21brugada syndrome10.1OXTR, SLC6A4
22hypertrophic elongation of cervix10.1CRP, IL4
23breast reconstruction10.1COMT, DRD2
24colorectal adenocarcinoma10.1COMT, DRD2, SLC6A4
25cytomegalic congenital adrenal hypoplasia10.1COMT, DRD2, SLC6A4
26dry eye syndrome10.1HTR1A, SLC6A4
27cholesteatoma10.1COMT, DRD2, SLC6A4
28hereditary multiple exostoses10.1COMT, DRD2, SLC6A4
29anodontia10.1HTR1A, SLC6A4
30adult brainstem astrocytoma10.1HTR1A, SLC6A4
31eating disorder10.0
32kidney pelvis papillary carcinoma10.0HTR1A, SLC6A4
33hypoglycemia10.0ANKK1, DRD2, SLC6A4
34myiasis10.0CRP, IL4
35tinea pedis10.0HTR1A, SLC6A4
36basal cell carcinoma 310.0ANKK1, COMT, DRD2
37hypoglycemic coma10.0HTR1A, SLC6A4
38somatoform disorder10.0
39patellar tendinitis10.0IL4, TAS2R38
40chorea gravidarum10.0DRD2, HTR1A
41renpenning syndrome10.0COMT, HTR1A, SLC6A4
42panic disorder10.0
43chronic eosinophilic pneumonia10.0COMT, HTR1A, SLC6A4
44multiple personality disorder10.0COMT, HTR1A, SLC6A4
45primary angle-closure glaucoma10.0COMT, HTR1A, SLC6A4
46keratosis10.0COMT, HTR1A, SLC6A4
47allergic hypersensitivity disease10.0DRD2, HTR1A
48vascular cancer9.9DRD2, HTR1A
49lichen disease9.9COMT, HTR1A, SLC6A4
50fechtner syndrome9.9COMT, HTR1A, SLC6A4

Graphical network of the top 20 diseases related to Alexithymia:



Diseases related to alexithymia

Symptoms & Phenotypes for Alexithymia

About this section

GenomeRNAi Phenotypes related to Alexithymia according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00359-A8.5ANKK1, COMT, HTR1A, SLC6A4

Drugs & Therapeutics for Alexithymia

About this section

Drugs for Alexithymia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SertralineapprovedPhase 429979617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-sertraline
sertraline
sertraline (Zoloft)
2Serotonin AgentsPhase 4, Phase 23156
3Serotonin Uptake InhibitorsPhase 41587
4
SerotoninPhase 4, Phase 2362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
5Psychotropic DrugsPhase 4, Phase 26430
6Neurotransmitter AgentsPhase 4, Phase 218340
7Neurotransmitter Uptake InhibitorsPhase 4, Phase 23521
8Antidepressive AgentsPhase 42736
9
Oxytocinapproved, vet_approvedPhase 243950-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
10
3,4-Methylenedioxyamphetamineexperimental, illicitPhase 2344764-17-41614
Synonyms:
(RS)-3,4-(methylenedioxy)methamphetamine
1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine
1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine
3,4-Methylenedioxymethamphetamine
 
DL-(3,4-Methylenedioxy)methamphetamine
MDMA
N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine
N-Methyl-3,4-methylenedioxyamphetamine
Tenamfetamine
11OxytocicsPhase 2707
12HallucinogensPhase 2179
13N-Methyl-3,4-methylenedioxyamphetaminePhase 237
14Adrenergic AgentsPhase 25352
15
Acetylcysteineapproved, investigationalPhase 1330616-91-112035
Synonyms:
(2R)-2-acetylamino-3-sulfanylpropanoic acid
(R)-2-acetylamino-3-mercaptopropanoic acid
(R)-mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
Fluprowit
 
L-Acetylcysteine
L-acetylcysteine
L-α-acetamido-β-mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetyl-L-(+)-cysteine
N-acetyl-L-cysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
16Protective AgentsPhase 17443
17VitaminsPhase 15282
18N-monoacetylcystinePhase 1330
19Respiratory System AgentsPhase 14997
20AntioxidantsPhase 13050
21ExpectorantsPhase 1404
22Anti-Infective AgentsPhase 122062
23AntidotesPhase 11071
24Antiviral AgentsPhase 19967
25
Hydrocortisoneapproved, vet_approved66750-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
26
Dopamineapproved383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
27
Norepinephrineapproved69951-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
28Duloxetine Hydrochloride270
29Peripheral Nervous System Agents23689
30Serotonin and Noradrenaline Reuptake Inhibitors457
31Dopamine Agents3836
32Hydrocortisone 17-butyrate 21-propionate667
33Anti-Inflammatory Agents10729
34Cortisol succinate667
35Hydrocortisone acetate667
36Analgesics11733

Interventional clinical trials:

(show all 30)
idNameStatusNCT IDPhase
1Clinical Assessment and Psychosocial Impact of PsoriasisCompletedNCT01964443Phase 4
2Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress DisorderCompletedNCT00391430Phase 4
3Pain and Stress Management for FibromyalgiaCompletedNCT01287481Phase 2
4Ocytocine and Cerebral Activation in Relation With AttachementRecruitingNCT02847143Phase 2
5Autism Oxytocin Brain ProjectRecruitingNCT03033784Phase 2
6MDMA-assisted Therapy for Social Anxiety in Autistic AdultsActive, not recruitingNCT02008396Phase 2
7Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in AdolescentsCompletedNCT01111734Phase 1
8Neurobiological, Neuropsychological,Linguistic and Gestural Processes and Phenomena in Individuals With AlexithymiaUnknown statusNCT00830752
9Psychological Impact in Diabetes: Intervention With Affect School and Basal Body AwarenessUnknown statusNCT01498614
10Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to DementiaUnknown statusNCT01436552
11The Emotion Builder: An Intervention for Emotional Deficits After Brain InjuryCompletedNCT02432300
12Online Treatment of TrichotillomaniaCompletedNCT02044237
13Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSSTCompletedNCT00451126
14Effectiveness of Standard Emergency Department Psychiatric Treatment Associated With Treatment Delivery by a Suicide Prevention CenterCompletedNCT00641498
15Service Member Fatigue and Lack of Motivation Following ConcussionCompletedNCT01496586
16Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)CompletedNCT01564667
17Functional Neuroanatomy and Regional Metabolism Before and After Treatment With DuloxetineCompletedNCT02658617
18Depression Online Assessment and TherapyCompletedNCT02112266
19Stress Management for Irritable Bowel SyndromeCompletedNCT01886027
20Plasticity of the Compassionate BrainCompletedNCT01833104
21Positive Emotion Regulation Training in Children, Adolescents and Young Adults With and Without Developmental DisorderRecruitingNCT02898298
22A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled TrialRecruitingNCT02859935
23Mental Training for CFS Following EBV Infection in AdolescentsRecruitingNCT02499302
24Oculomotor Markers and Attachment in AdolescentsRecruitingNCT02851810
25Randomized Controlled Study of the Efficacy of Hypnosis Versus Relaxation and Control in Neuropathic PainRecruitingNCT02256371
26Student Outcomes of Integrative Mental Health ServicesRecruitingNCT02877875
27Halifax Treatment Refractory Depression TrialActive, not recruitingNCT01141426
28Mindfulness for Irritable Bowel SyndromeActive, not recruitingNCT02794376
29Psychological Variables and Hyperglycemia in Diabetes MellitusEnrolling by invitationNCT01714986
30CBT-Eb Plus EMDR Versus CBT-Eb in Patients With Eating DisordersNot yet recruitingNCT03156959

Search NIH Clinical Center for Alexithymia

Genetic Tests for Alexithymia

About this section

Anatomical Context for Alexithymia

About this section

MalaCards organs/tissues related to Alexithymia:

36
Brain, Breast, Testes, Cortex, Heart, Skin, Thyroid

Publications for Alexithymia

About this section

Articles related to Alexithymia:

(show top 50)    (show all 637)
idTitleAuthorsYear
1
The mediating effects of cognitive emotion regulation strategies on the relationship between alexithymia and physical symptoms: Evidence from Iranian asthmatic patients. (27898375)
2017
2
Reductions in Alexithymia and Emotion Dysregulation After Training Emotional Self-Awareness Following Traumatic Brain Injury: A Phase I Trial. (28060205)
2017
3
Alexithymia as a Moderator of Treatment Outcomes in a Randomized Controlled Trial on Brief Psychodynamic Interpersonal Psychotherapy for Patients with Multisomatoform Disorder. (27884003)
2017
4
Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control. (27499615)
2016
5
Corrigendum to "DRD2/ANKK1 TaqI A genotype moderates the relationship between alexithymia and the relative value of alcohol among male college binge drinkers" [Pharmacol. Biochem. Behav. 102 (2012) 471-476]. (27045283)
2016
6
Describe Your Feelings: Body Illusion Related to Alexithymia in Adolescence. (27840618)
2016
7
The Big Five personality dimensions and mental health: The mediating role of alexithymia. (27931909)
2016
8
Predictors for DSM-5 nonsuicidal self-injury in female adolescent inpatients: The role of childhood maltreatment, alexithymia, and dissociation. (27088878)
2016
9
Alexithymia, not autism, is associated with impaired interoception. (27253723)
2016
10
Alexithymia, empathy, emotion identification and social inference in anorexia nervosa: A case-control study. (27086047)
2016
11
Reduced anticipation of negative emotional events in alexithymia. (27278856)
2016
12
Association between the Catechol-O-Methyltransferase (COMT) ValA^a8/a8,Met Polymorphism and Alexithymia in Patients with Obsessive-Compulsive Disorder. (26996573)
2016
13
Borderline Personality Disorder Symptoms in College Students: The Complex Interplay between Alexithymia, Emotional Dysregulation and Rumination. (27348858)
2016
14
Extreme sensory processing patterns show a complex association with depression, and impulsivity, alexithymia, and hopelessness. (28064114)
2016
15
Interpersonal-Psychological Theory, Alexithymia, and Personality Predict Suicide Ideation among Maladjusted Soldiers in Taiwan. (27883207)
2016
16
Empathy in depression: Egocentric and altercentric biases and the role of alexithymia. (27060429)
2016
17
Examining the Effects of Alexithymia on the Relation Between Posttraumatic Stress Disorder and Over-Reporting. (27268098)
2016
18
Touching the Lived Body in Patients with Medically Unexplained Symptoms. How an Integration of Hands-on Bodywork and Body Awareness in Psychotherapy may Help People with Alexithymia. (26973560)
2016
19
Apathy, alexithymia, and depressive symptoms: Points of convergence and divergence. (27512920)
2016
20
Alexithymia in Chronic Pain Disorders. (27215759)
2016
21
Commentary: Alexithymia, not autism, is associated with impaired interoception. (27501009)
2016
22
Alexithymia: a general deficit of interoception. (27853532)
2016
23
Alterations in the Emotional Regulation Process in Gambling Addiction: The Role of Anger and Alexithymia. (27550365)
2016
24
Cross-cultural validation of the 20-item Toronto Alexithymia Scale in Chinese adolescents. (27028136)
2016
25
Exploring the interrelationship between alexithymia, defense style, emotional suppression, homicide-related posttraumatic stress disorder and psychiatric co-morbidity. (27449006)
2016
26
An Examination of the Topology and Measurement of the Alexithymia Construct Using Network Analysis. (27217088)
2016
27
Impulsivity, alexithymia and dissociation among pathological gamblers in different therapeutic settings: A multisample comparison study. (28029440)
2016
28
Childhood Trauma and Alexithymia in Patients with Conversion Disorder. (27504555)
2016
29
Default Mode Network alterations in alexithymia: an EEG power spectra and connectivity study. (27845326)
2016
30
Individual differences in emotional processing and autobiographical memory: interoceptive awareness and alexithymia in the fading affect bias. (27556549)
2016
31
Possible common neurological breakdowns for alexithymia and humour appreciation deficit: A case study. (27987387)
2016
32
Predicting symptoms in major depression after inpatient treatment: the role of alexithymia. (26935972)
2016
33
Alexithymia, but not autism spectrum disorder, may be related to the production of emotional facial expressions. (27895883)
2016
34
Alexithymia and Emotional Processing: A Mediation Model. (28026885)
2016
35
The association between depression and craving in alcohol dependency is moderated by gender and by alexithymia factors. (27137959)
2016
36
Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis. (27565774)
2016
37
Alexithymia and psychopathological symptoms in adolescent outpatients and mothers suffering from migraines: a case control study. (27093870)
2016
38
Alexithymia and psychopathology in patients with acute myocardial infarction. (27090044)
2016
39
Investigation of facial emotion recognition, alexithymia, and levels of anxiety and depression in patients with somatic symptoms and related disorders. (27199559)
2016
40
Effects of alexithymia and empathy on the neural processing of social and monetary rewards. (27866269)
2016
41
Alexithymia and psychosocial problems among Italian preadolescents. A latent class analysis approach. (27376760)
2016
42
From Childhood Trauma to Adult Dissociation: The Role of PTSD and Alexithymia. (27623153)
2016
43
Alexithymia in Parkinson's disease: A systematic review of the literature. (27086264)
2016
44
Relationship between internet addiction and alexithymia among university students. (27917803)
2016
45
Impaired emotion recognition is linked to alexithymia in heroin addicts. (27069803)
2016
46
Taking time to feel our body: Steady increases in heartbeat perception accuracy and decreases in alexithymia over 9 months of contemplative mental training. (27925645)
2016
47
What's in the name 'alexithymia'? A commentary on "Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy.". (27235080)
2016
48
The role of alexithymia: An 8-year follow-up study of chronic pain patients. (27423355)
2016
49
Prevalence and Demographic Correlates of Alexithymia: A Comparison Between Australian Psychiatric and Community Samples. (27129142)
2016
50
Psychological Distress Mediates the Effect of Alexithymia on 2-Year Change in HIV Viral Load. (27882489)
2016

Variations for Alexithymia

About this section

Expression for genes affiliated with Alexithymia

About this section
Search GEO for disease gene expression data for Alexithymia.

Pathways for genes affiliated with Alexithymia

About this section

GO Terms for genes affiliated with Alexithymia

About this section

Biological processes related to Alexithymia according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1response to amphetamineGO:000197510.4DRD2, OXTR
2response to cocaineGO:004222010.4DRD2, OXTR
3dopamine metabolic processGO:004241710.3COMT, DRD2
4response to cytokineGO:003409710.2IL4, OXTR
5social behaviorGO:003517610.1OXTR, SLC6A4
6sperm ejaculationGO:004271310.1OXTR, SLC6A4
7female pregnancyGO:00075659.7COMT, IL4, OXTR
8response to organic cyclic compoundGO:00140709.5COMT, IL4, OXTR
9vasoconstrictionGO:00423109.3HTR1A, SLC6A4
10response to drugGO:00424938.9COMT, DRD2, IL4, OXTR, SLC6A4

Molecular functions related to Alexithymia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1G-protein coupled receptor activityGO:00049309.0DRD2, HTR1A, OXTR, TAS2R38
2signal transducer activityGO:00048718.4DRD2, HTR1A, OXTR, TAS2R38

Sources for Alexithymia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet